generic_link-64

Report by Raffles Family Office and Campden Wealth finds 47% of APAC family offices to be controlled by next-gen in five years, only 56% feel well prepared for succession

ZaiLab_EN_logo_-XL-RGB

Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China’s National Reimbursement Drug List

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2023 National Reimbursement Drug List...